Sphingolipids / PUFA and Respiratory Syndrome

99K

views

36

authors

10

articles

Editors

3

Hridayesh Prakash

Amity Centre for Translational Research

Downstate Health Sciences University

Cornell University

Impact

About

Sphingolipids and PUFA are crucial bioactive molecules and involved in several fundamental and patho-physiological conditions like asthma, cystic fibrosis, respiratory tract infection and acute lung injuries. Among various intracellular kinases; Sphingosine kinase is crucial and central for Sphingolipids metabolism. SphK-1 is a well-known regulator of intracellular calcium homeostasis, cellular differentiation, innate immunity; apoptosis and cancer while the role of these lipids remains unclear. Sphingosine kinase-1 / has shown some therapeutic importance for controlling pulmonary infection with Mycobacteria. Therefore, the current topic is introduced to foster / welcome research activities across the globe targeting various sphingolipids and their derivatives for the effective management of pulmonary infection with pathogenic bacteria and discuss the therapeutic benefits of sphingolipid in controlling respiratory syndrome among various research groups/ labs for future collaboration.

Sphingolipids and PUFA are crucial bioactive molecules and involved in several fundamental and patho-physiological conditions like asthma, cystic fibrosis, respiratory tract infection and acute lung injuries. Among various intracellular kinases; Sphingosine kinase is crucial and central for Sphingolipids metabolism. SphK-1 is a well-known regulator of intracellular calcium homeostasis, cellular differentiation, innate immunity; apoptosis and cancer while the role of these lipids remains unclear. Sphingosine kinase-1 / has shown some therapeutic importance for controlling pulmonary infection with Mycobacteria. Therefore, the current topic is introduced to foster / welcome research activities across the globe targeting various sphingolipids and their derivatives for the effective management of pulmonary infection with pathogenic bacteria and discuss the therapeutic benefits of sphingolipid in controlling respiratory syndrome among various research groups/ labs for future collaboration.

Share

Editors

Hridayesh Prakash

Amity Centre for Translational Research

Downstate Health Sciences University

Cornell University

Impact

98,960 Total views

68,206 Article views

28,710 Article downloads

2,044 Topic views

Published In

Journal Thumbnail

Frontiers in Immunology

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic